SCHEMBL16458602

SCHEMBL16458602

CCCCCCCCCCCCCC[CH]C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.57
SOAT1 P35610 2/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
TP53 P04637 1/20 0.57
CYP3A4 P08684 1/20 0.57
KDM4E B2RXH2 2/20 0.52
CNR1 P21554 1/20 0.48
EP300 Q09472 1/20 0.48
TSHR P16473 1/20 0.48
TERT O14746 3/20 0.47
MAPT P10636 2/20 0.47
BLM P54132 2/20 0.47
HSD17B10 Q99714 2/20 0.47
FABP4 P15090 2/20 0.47
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10656809 1.00 FAAH (0.57) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL7146817 1.00 FAAH (0.57) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL9759038 1.00 FAAH (0.57) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL28178796 1.00 FAAH (0.57) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL11316842 1.00 FAAH (0.57) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL11322157 1.00 FAAH (0.57) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL1416084 0.98
SCHEMBL196011 0.90
SCHEMBL1276035 0.78 EP300 (0.56) FAAHCYP1A2CYP2C19KMT2AEP300
SCHEMBL3124771 0.78 EP300 (0.56) FAAHCYP1A2CYP2C19KMT2AEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107205401-A Microbiocidal control in poultry processing 雅宝公司 2017-09-26 CN disclosed
US-20140011738-A1 GLUCAGON ANALOGS EXHIBITING GIP RECEPTOR ACTIVITY INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2014-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140011738-A1 GLUCAGON ANALOGS EXHIBITING GIP RECEPTOR ACTIVITY GLP1R, GIPR, GCGR FAAH 1537/4885SOAT1 2065/4885CYP1A2 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.